Prefillable Syringes
•12 stocks
•
Total Market Cap: Loading...
Market Cap Distribution
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (12)
%
| Company | Market Cap | Price |
|---|---|---|
|
BD provides pre-filled syringe drug-delivery formats used in ready-to-administer therapies.
|
$53.47B |
$186.56
-1.50%
|
|
Prefillable Syringes indicating self-injection delivery formats for antibody therapies.
|
$47.65B |
$796.92
-0.76%
|
|
Integrated prefilled syringe system development aligns with Prefillable Syringes.
|
$18.81B |
$261.77
-1.19%
|
|
Nexa high-value syringes indicate a core prefillable syringe product line.
|
$7.22B |
$23.85
-0.58%
|
|
Direct product category: prefillable syringes used for ready-to-administer injections.
|
$834.00M |
$14.47
+1.47%
|
|
Plans to launch via prefilled syringes reflect a ready-to-use delivery format for ocular injections.
|
$626.30M |
$11.87
-11.42%
|
|
Fillers are administered via prefilled syringe formats, aligning with Prefillable Syringes as a direct product format for Evolus' injectable products.
|
$395.88M |
$6.14
-1.92%
|
|
The autoinjector development implies readiness-to-administer drug delivery components (prefillable/syringe-based delivery subcategory).
|
$299.33M |
$5.67
|
|
Installation of a high-speed aseptic isolator filler enables filling of vials, cartridges, and prefilled syringes (Prefillable Syringes).
|
$240.66M |
$6.50
-2.40%
|
|
The company emphasizes compatibility with prefilled syringes, a core feature of its delivery platform.
|
$197.94M |
$4.29
+0.23%
|
|
Prefillable syringes are a distinct product line within MHUA's disposable devices.
|
$10.18M |
$0.39
-6.47%
|
|
Next-generation, polymer-based, prefillable syringe formulations represent a major product initiative and growth vector.
|
$6.01M |
$5.90
-11.28%
|
Loading industry metrics...
Loading comparison data...
